This course is a production of a recent Virtual Symposium and Special General Meeting Day 1 held on 29th October 2020 by KCS intended for clinicians and other healthcare providers in Kenya regarding SGLT-2 inhibitors.
The course objectives include:
1. Serving as an educational aid and reference material for clinicians as well as other healthcare workers regarding heart failure (HF) and diabetes.
2. Disseminate information and knowledge to health care workers on SGLT-2 inhibitors-cardiovascular outcome trials in HF and diabetes amongst others.
The course includes recorded videos in lecture style, videos of practical skills.
Part 1: Introduction
Part 2: SGLT-2 inhibitors-cardiovascular outcome trials in HF and diabetes